ProCE Banner Activity

New Advances in Antibody–Drug Conjugates and Other Immunotherapeutic Agents

Slideset Download
Farhad Ravandi, MD, examines current and investigational AML treatment approaches using antibody-drug conjugates and other immunotherapies.

Released: December 09, 2019

Expiration: December 07, 2020

No longer available for credit.

Share

Faculty

Farhad Ravandi

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

Provided by National Comprehensive Cancer Network.
ProCE Banner

Supporters

Supported by educational grants from

Actinium

Boston Biomedical

Jazz Pharmaceuticals Inc

Pfizer, Inc.

Partners

NCCN

ProCE Banner

Faculty Disclosure

Primary Author

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Farhad Ravandi, MD, examines current and investigational AML treatment approaches using antibody-drug conjugates and other immunotherapies.